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W. ANDREW DICKINSON, JR., M.D. 
Internal Medicine and Cardiology, Virginia Beach. Virginia 
Accepting that hypertension occurs in an esti­
mated 20% of the adult population in the United 
States (I) and that it is a leading risk factor in the 
development of vascular disease (2, 3 ), physicians are 
being challenged to assume a more pragmatic ap­
proach to the differential diagnosis of hypertension 
than has been promoted in the past. 
Detection. The levels of blood pressure defining 
hypertension vary, but 140/90 in patients under age 
40 and 160/95 in patients over age 40, are generally 
accepted (I). Such elevated recordings in the office, 
screening program, or upon admission to the hospital 
should be followed by three successive recordings 
made by the physician or trained nursing personnel 
to definitely determine that the patient has hyperten­
sion and that the original reading was not falsely 
elevated because of emotional factors surrounding 
the initial examination. Bed rest for hospitalized 
patients will yield normal blood pressure recordings, 
and an initial recording which is elevated should be 
followed by repeated recordings after the patient has 
returned to normal daily living. 
Recording of the blood pressure, though simple, 
should be properly performed to avoid categorizing a 
patient in a group already challenging the system's 
ability to evaluate and treat those in need. With the 
use of two sets of stethophones connected to a single 
diaphragm, it is quite easy to instruct office per­
sonnel in proper auscultation of the blood pressure. 
When the mercury manometer is used, the meniscus 
should be at point 'O' when deflated, and the mercury 
column should fall freely with a good air flow into 
the top of the manometer. Aneroid manometers 
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should be standardized with a Y-tubing against a 
mercury manometer for accuracy. The bladder of the 
blood pressure cuff should be placed over the bra­
chia! artery, and the bell or diaphragm of the steth­
ophone over the pulsating vessel in the anticubital 
fossa. The patient should be resting for at least five 
minutes and the blood pressure initially recorded in 
the supine or sitting position. The cuff should be 
inflated until the radial pulse can no longer be felt 
and then deflated at approximately 2 to 3 mm/sec­
ond. The initial sound (phase I) is recorded as the 
systolic pressure, with the point of disappearance 
(phase V) coinciding best with intra-arterial diastolic 
pressure (4). Where phase V is over 5 mm lower than 
the point of muffling (phase IV), both numbers 
should be recorded. Patients with bruits in their arms 
due to partial stenosis of the artery, as well as those 
with aortic insufficiency and hyperkinetic circulations 
from other causes, may not have disappearance of 
Korotkotfs sounds until near ·o·. In these instances, 
phase IV, or muffling, is used as the diastolic pres­
sure. 
Recordings should be made in both arms, where 
up to 10 mm Hg difference in pressure may be nor­
mally noted: greater differences should suggest the 
possibility of some intra-arterial obstruction to that 
extremity. In patients who are markedly obese, a 
thigh cuff should be used in the upper arm and may 
be more accurate than recording the blood pressure 
in the forearm. Pumping the cuff up rapidly, keeping 
the recording arm elevated, as well as allowing 15 
seconds or more between recordings, will prevent 
venous engorgement, which might affect the arterial 
pressure. 
In addition to blood pressure determinations ly­
ing and sitting, the blood pressure should be recorded 
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immediately after the patient assumes the standing 
position and one minute after. The degree of postural 
drop in blood pressure may be marked in lean 
patients, particularly in the older age group, and 
greatly influences not only the patient's further eval­
uation but also the selection of therapy. 
Etiology. In the past, an estimated IO% to 15% or 
more of hypertensives have been defined as having 
curable causes, though Gifford (5) found that less 
than 6% of 5,000 hypertensive patients at the Cleve­
land Clinic have potentially curable forms of hyper­
tension. In the average primary medical practice, the 
figure for curable hypertension may be even less, per­
haps 2%; that is. over 98% of patients may have hyper­
tension which is either essential or due to renal pa­
renchymal disease. 
Essential Hypertension. In essential hyperten­
sives, the age at which hypertension was first de­
tected, or when normal blood pressure was last docu­
mented, should be sought. Essential hypertension 
usually begins at the third and fourth decade of life 
and progresses through the years. A family history of 
hypertension. or vascular complications related to 
hypertension. is often obtained. The Systems Review 
should be directed at detecting evidence of organ 
damage such as cerebrovascular insufficiency, vision 
impairment, arteriosclerotic heart disease, as well as 
claudication. Most patients will either be entirely 
asymptomatic or present with manifestations of 
target organ dysfunction as the main complaint. 
An ophthalmoscope, which can be carried in the 
breast pocket, facilitates funduscopy. and most 
patients will be found to have normal fundi or per­
haps grade I changes due to arteriolosclerosis mani­
fested by an increased light reflex ("copper wire 
changes"). with occasionally more advanced changes 
of A-V nicking and compression, all of which relate 
more to the duration of hypertension, rather than to 
its severity. Rarely, one will see retinal hemorrhages, 
exudates, and/or papilledema in the patient with ac­
celerated, "malignant" hypertension. Bruits over the 
carotid arteries indicate the likelihood of athe­
rosclerotic plaques in these vessels and suggest not 
only the degree of atherosclerosis present, but should 
also alert the physician to possible side effects with 
future drug therapy which might cause postural 
hypotension and neurological complications. A dif­
fuse left ventricular impulse over the precordium sug­
gests left ventricular hypertrophy due to hyperten­
sion, or dilatation as a result of a dyskinetic area of 
the left ventricle affected by ischemic heart disease. 
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An S-4 gallop sound is heard in patients with more 
severe hypertension. Palpation of the abdominal 
aorta for an aneurysm, as well as the pulses in the 
lower extremities, add further to the evaluation of the 
total vascular picture. 
Laboratory studies should include a CBC and an 
SMA-12, or at least a cholesterol, 2 hr. p.c. sugar, 16 
hr. fasting triglyceride level, and a urinalysis. A base­
line electrocardiogram and P-A radiograph of the 
chest for evidence of left ventricular hypertrophy or 
enlargement should be obtained and used for com­
parison with future studies. 
Chronic Renal Disease. Proteinuria, particularly 
when accompanying or preceding the onset of hyper­
tension by history, or when associated with a history 
of glomerulonephritis or repeated pyelonephritis, sug­
gests primary renal disease as the cause for hyperten­
sion. An abnormal urinary sediment including white 
blood cells, red blood cells, and/or casts further sug­
gests such an etiology. An elevated creatinine, with 
intravenous pyelogram (IVP) demonstration of 
kidneys which are contracted, polycystic, or with 
typical changes of chronic infection may also serve 
to document this etiology. 
Renal Artery Stenosis. Of the curable forms of 
hypertension, renal artery stenosis probably repre­
sents the larger group, though it still represents a 
small number of patients in the average practice. The 
abrupt onset of hypertension, particularly in the age 
groups below 40, and particularly in females, more 
likely suggests fibromuscular disease of a renal artery. 
The rather abrupt onset of hypertension in older age 
groups that were previously normotensive also sug­
gests a stenotic lesion, but one due to atherosclerosis. 
Hypertensive patients under therapy who are increas­
ingly difficult to control might also be suspected of 
having renal artery stenosis. The history, except in 
regard to the progression of the hypertension itself, is 
usually unrevealing. It should be noted that renal 
artery stenosis is not often seen in blacks. The pres­
ence of vascular spasm on funduscopy suggests a 
more acute onset of hypertension. 
A rapid sequence IVP revealing delayed appearance 
of contrast media by one kidney suggests that it is 
inadequately perfused. A difference in kidney size is 
significant if the left kidney is more than 1.5 cm 
shorter than the right, or if the right kidney is 2.0 cm 
or more shorter than the left, the right kidney being 
normally shorter than the left. Aortography should 
be performed if pyelography suggests unilateral renal 
disease. and even when the IVP is normal, if the clinical 
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picture is strongly suggestive, since there are signifi­
cant numbers of false-negative IVP's. On physical 
examination, systolic bruits in the epigastrium are 
not sufficiently reliable in the diagnosis of renal artery 
stenosis, though a systolic murmur with a diastolic 
component would be strongly suggestive. The demon­
stration of stenosis in a renal vessel does not mean 
that such a kidney is inadequately perfused, or that 
inadequate perfusion is the cause of the patient's hy­
pertension, since renal artery stenosis may exist in 
normotensive patients. 
Plasma renin vein assays may also be normal or 
elevated. It is, therefore, necessary to obtain renal 
vein renin ratios by catheterization of each of the 
renal veins. Following a period of salt deprivation, 
and three hours after 80 mg of furosemide by mouth, 
if the renin level from the suspected kidney is 1.5 to 2 
times that of the anatomically normal kidney, and 
particularly if the contra-lateral kidney renin level is 
lower than the peripheral plasma renin, then the sus­
pected kidney is probably contributing to the hyper­
tension. Further confirmation is available by the ad­
ministration of an analog of angiotensin 11, the 
potent vasopressor responsible for the hypertension 
in renal artery stenosis, that can be used to block 
angiotensin II. When the analog produces a clear-cut 
lowering of blood pressure when given intravenously, 
this would further support the suspicion that renal 
artery stenosis is causing the hypertension (6 ). This 
analog is saralasin acetate and is still under in­
vestigation for general use. 
Primary Aldosteronism. An even more rare cause 
of hypertension is primary aldosteronism. Such 
patients may present with a history of weakness, 
muscle cramps, and paresthesias, but will more likely 
be detected by the finding of hypokalemia. When 
such is documented on repeated determinations of 
the serum potassium in a patient who has not been on 
diuretics or a low-salt diet or who does not have other 
clinical causes for hypokalemia, such as diarrhea, 
vomiting, and so forth, then a 24-hour urine sample 
for total potassium should be obtained. If the patient 
has been off diuretics for at least three days and the 
potassium excretion exceeds 30 to 40 mEq in 24 
hours, then excessive aldosterone effect must be con­
sidered. Such patients must be on an adequate salt 
intake diet before urinary measurements of potas­
sium are made, as well as the analyses of plasma renin 
and aldosterone levels, which will be needed to fur­
ther confirm this diagnosis. High levels of aldoste­
rone, accompanied by abnormally low levels of renin, 
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are diagnostic of this disease, but do not determine 
whether such are due to an isolated adenoma of the 
adrenal cortex or to bilateral nodular hyperplasia. 
Visualization of the adrenal glands prior to surgery is 
recommended since patients with bilateral adrenal 
hyperplasia present a more serious problem for 
surgical, as well as subsequent endocrine management, 
and such patients usually respond quite well to 
medical management with spironolactone. 
Pheochromocytoma. Most patients with 
pheochromocytoma will be symptomatic with fluc­
tuating blood pressure due to the intermittent dis­
charge of catecholamines. Headaches, nervousness, 
palpitations, and sweating are the usual symptoms. 
These patients are rarely overweight, and the pres­
ence of obesity would make the diagnosis unlikely. 
Laboratory studies are usually not necessary to ex­
clude this diagnosis, but if suspected, a metanephrine 
screening test of the urine should be obtained. If this 
is positive, free catecholamines can be measured in a 
24-hour urine sample. Drugs and dietary factors, 
which complicate measurement of VMA, make this 
test of limited value. 
Cushing's Disease. The typical Cushingoid fea­
tures, together with evidence of carbohydrate intoler­
ance, make this diagnosis one to be considered, 
though the overwhelming majority of such patients 
suspected on this basis, will turn out not to have the 
disease. Measurement of plasma cortisol on a 7 AM 
specimen, after administration of 1.0 mg dexametha­
sone at bedtime the night before, if supressed below 
normal values, all but excludes completely such a 
diagnosis. 
Coarctation of the Aorta. Simple palpation of the 
pulses in the lower extremities and comparing their 
volume and time of onset with that in the radial or 
carotid pulse is usually all that is necessary to lead 
one to consider the possibility of coarctation. If there 
is a pulse lag and diminished or absent pulses in the 
legs, then the blood pressure should be recorded, if 
possible, in the arm and thigh. Normally, the thigh 
blood pressure exceeds the arm blood pressure and if 
the opposite is evident, then the diagnosis of coarcta­
tion will need to be pursued further. 
"The Pill." The use of oral contraceptives may 
cause reversible hypertension and is probably one of 
the more common causes of curable hypertension 
among the others mentioned, in the average popu­
lation. Discontinuing oral contraceptives will result 
in the return of blood pressure to normal within sev­
eral months. 
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Classification of Hypertensive Patients by Renin 
Assay. Renin is produced and released by the jux­
taglomerular apparatus in the kidney in response to 
the pressure in the afferent arteriole and by the so­
dium level in the macula densa of the kidney. Normal 
physiological factors which lower renal artery pres­
sure cause increased renin release. whereas factors 
which increase renal artery pressure cause a decrease 
in renin levels. Similarly. diminished sodium effect. 
such as seen in salt depletion. results in increased 
renin release. whereas increased sodiurn effect on the 
blood pressure is associated with suppressed renin 
levels (7). The compensatory mechanisms for restora­
tion of normal pressure and sodium effect on the 
blood pressure come about through renin innuence 
on the production of more, or Jess. angiotensin 11. the 
potent vasopressor circulating agent. Angiotensin 11 
further inAuences the release of aldosterone from the 
adrenal cortex which when increased results in in­
creased sodium and Auid retention as a result of its 
effect on the renal tubule (8 ). 
Plasma vein renin assay (PVRA) is actually a 
measurement of the amount of angiotensin I (the 
inactive precursor of angiotensin 11) formed from a 
substrate over a given period of incubation time. Re­
n in levels are expressed as ng/cc/hr of incubation 
and are commercially available by radioimmunoas­
say techniques. Such plasma renin activity is com­
pared with those determined to be within the low. 
normal. or elevated levels for the particular labo­
ratory. Reliable PY RA requires that the sodium-vol­
ume status of the patient not be disrupted by outside 
influences such as diets. and so forth, and most of the 
commonly used hypertensive drugs, as well as oral 
contraceptives, must be omitted temporarily to ob­
tain diagnostic and unprovoked results. Approx­
imately 25% to 30% of patients with essential hyper­
tension will have low renin levels, whereas a 
somewhat smaller number will have high renin levels, 
with a slight majority having normal renin levels (9). 
Determination of renin levels in patients with essen­
tial hypertension has been advanced by some who 
have studies to indicate that renin may be toxic to the 
vascular system and should be treated with renin­
loweri ng drugs ( I 0, 1 1) such as propra nolol or meth­
yldopa. Other studies do not confirm this (9). Others 
have proposed a diagnostic trial of antihypertensive 
drugs with known effect on renin activity, as a better 
approach than using the renin levels per se; that is. 
a propranolol or methyldopa response suggesting 
increased renin hypertension, whereas diuretic re-
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sponsiveness would suggest low or normal renin 
levels. 
Conclusion. The overwhelming majority of hy­
pertensive patients have essential hypertension, 
which is a potent risk factor in producing vascular 
disease. Overall. it must be stated that the differential 
diagnosis of hypertension is a relatively minor factor 
in approaching the tremendous challenge of detecting 
and adequately treating the overwhelming majority 
of patients who are now undetected, untreated, or 
inadequately treated. 
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